Cite
HARVARD Citation
Pineda, E. et al. (2017). Dynamic soluble changes in sVEGFR1, HGF, and VEGF promote chemotherapy and bevacizumab resistance: A prospective translational study in the BECOX (GEMCAD 09-01) trial. Tumor biology. 39 (6), p. . [Online].